Annual Working Capital
$120.26 M
-$21.59 M-15.22%
September 30, 2024
Summary
- As of February 7, 2025, AVXL annual working capital is $120.26 million, with the most recent change of -$21.59 million (-15.22%) on September 30, 2024.
- During the last 3 years, AVXL annual working capital has fallen by -$30.56 million (-20.26%).
- AVXL annual working capital is now -20.26% below its all-time high of $150.82 million, reached on September 30, 2021.
Performance
AVXL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$120.26 M
-$9.52 M-7.33%
September 30, 2024
Summary
- As of February 7, 2025, AVXL quarterly working capital is $120.26 million, with the most recent change of -$9.52 million (-7.33%) on September 30, 2024.
- Over the past year, AVXL quarterly working capital has dropped by -$9.52 million (-7.33%).
- AVXL quarterly working capital is now -23.47% below its all-time high of $157.15 million, reached on June 30, 2021.
Performance
AVXL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AVXL Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.2% | -7.3% |
| 3 y3 years | -20.3% | -20.3% |
| 5 y5 years | +492.7% | -20.3% |
AVXL Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.3% | at low | -21.0% | at low |
| 5 y | 5-year | -20.3% | +492.7% | -23.5% | +387.3% |
| alltime | all time | -20.3% | +3357.8% | -23.5% | +1995.1% |
Anavex Life Sciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $120.26 M(-15.2%) | $120.26 M(-7.3%) |
| Jun 2024 | - | $129.78 M(-3.8%) |
| Mar 2024 | - | $134.96 M(-0.5%) |
| Dec 2023 | - | $135.57 M(-4.4%) |
| Sep 2023 | $141.85 M(-0.4%) | $141.85 M(-3.3%) |
| Jun 2023 | - | $146.75 M(+1.1%) |
| Mar 2023 | - | $145.17 M(+7.4%) |
| Dec 2022 | - | $135.12 M(-5.2%) |
| Sep 2022 | $142.49 M(-5.5%) | $142.49 M(-5.5%) |
| Jun 2022 | - | $150.74 M(-1.0%) |
| Mar 2022 | - | $152.21 M(+4.0%) |
| Dec 2021 | - | $146.37 M(-3.0%) |
| Sep 2021 | $150.82 M(+453.7%) | $150.82 M(-4.0%) |
| Jun 2021 | - | $157.15 M(+107.3%) |
| Mar 2021 | - | $75.81 M(+63.7%) |
| Dec 2020 | - | $46.30 M(+70.0%) |
| Sep 2020 | $27.24 M(+34.2%) | $27.24 M(+10.4%) |
| Jun 2020 | - | $24.68 M(-0.4%) |
| Mar 2020 | - | $24.79 M(-4.5%) |
| Dec 2019 | - | $25.96 M(+27.9%) |
| Sep 2019 | $20.29 M(-8.5%) | $20.29 M(+16.1%) |
| Jun 2019 | - | $17.48 M(+23.3%) |
| Mar 2019 | - | $14.18 M(-17.7%) |
| Dec 2018 | - | $17.22 M(-22.3%) |
| Sep 2018 | $22.17 M(-8.4%) | $22.17 M(-5.8%) |
| Jun 2018 | - | $23.53 M(+5.1%) |
| Mar 2018 | - | $22.40 M(-12.1%) |
| Dec 2017 | - | $25.49 M(+5.3%) |
| Sep 2017 | $24.20 M(+286.9%) | $24.20 M(+3.4%) |
| Jun 2017 | - | $23.40 M(+9.2%) |
| Mar 2017 | - | $21.43 M(+12.1%) |
| Dec 2016 | - | $19.13 M(+205.7%) |
| Sep 2016 | $6.26 M(-51.2%) | $6.26 M(-18.4%) |
| Jun 2016 | - | $7.67 M(-20.8%) |
| Mar 2016 | - | $9.68 M(-15.7%) |
| Dec 2015 | - | $11.49 M(-10.3%) |
| Sep 2015 | $12.81 M | $12.81 M(+93.3%) |
| Jun 2015 | - | $6.63 M(+37.1%) |
| Mar 2015 | - | $4.83 M(-14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | $5.63 M(-4.7%) |
| Sep 2014 | $5.91 M(-479.0%) | $5.91 M(-6.1%) |
| Jun 2014 | - | $6.29 M(-14.2%) |
| Mar 2014 | - | $7.34 M(-538.8%) |
| Dec 2013 | - | -$1.67 M(+7.2%) |
| Sep 2013 | -$1.56 M(-45.8%) | -$1.56 M(-56.1%) |
| Jun 2013 | - | -$3.55 M(+3.4%) |
| Mar 2013 | - | -$3.43 M(+3.2%) |
| Dec 2012 | - | -$3.33 M(+15.8%) |
| Sep 2012 | -$2.88 M(+151.2%) | -$2.88 M(+30.8%) |
| Jun 2012 | - | -$2.20 M(-25.0%) |
| Mar 2012 | - | -$2.93 M(+18.0%) |
| Dec 2011 | - | -$2.48 M(+116.9%) |
| Sep 2011 | -$1.14 M(-61.4%) | -$1.14 M(+17.3%) |
| Jun 2011 | - | -$976.30 K(-20.8%) |
| Mar 2011 | - | -$1.23 M(+1167.5%) |
| Dec 2010 | - | -$97.20 K(-96.7%) |
| Sep 2010 | -$2.96 M(-19.7%) | -$2.96 M(-53.3%) |
| Jun 2010 | - | -$6.35 M(+42.1%) |
| Mar 2010 | - | -$4.46 M(+2.4%) |
| Dec 2009 | - | -$4.36 M(+18.1%) |
| Sep 2009 | -$3.69 M(+61.0%) | -$3.69 M(+33.7%) |
| Jun 2009 | - | -$2.76 M(-13.5%) |
| Mar 2009 | - | -$3.19 M(+15.8%) |
| Dec 2008 | - | -$2.76 M(+20.3%) |
| Sep 2008 | -$2.29 M(+395.8%) | -$2.29 M(+28.8%) |
| Jun 2008 | - | -$1.78 M(+62.8%) |
| Mar 2008 | - | -$1.09 M(+148.5%) |
| Dec 2007 | - | -$440.10 K(-4.8%) |
| Sep 2007 | -$462.50 K(+2883.9%) | -$462.50 K(+2.4%) |
| Jun 2007 | - | -$451.80 K(+129.5%) |
| Mar 2007 | - | -$196.90 K(+608.3%) |
| Dec 2006 | - | -$27.80 K(+79.4%) |
| Sep 2006 | -$15.50 K(-40.4%) | -$15.50 K(+59.8%) |
| Jun 2006 | - | -$9700.00(-74.3%) |
| Mar 2006 | - | -$37.80 K(+14.2%) |
| Dec 2005 | - | -$33.10 K(+27.3%) |
| Sep 2005 | -$26.00 K(-201.6%) | -$26.00 K |
| Sep 2004 | $25.60 K | - |
FAQ
- What is Anavex Life Sciences annual working capital?
- What is the all time high annual working capital for Anavex Life Sciences?
- What is Anavex Life Sciences annual working capital year-on-year change?
- What is Anavex Life Sciences quarterly working capital?
- What is the all time high quarterly working capital for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly working capital year-on-year change?
What is Anavex Life Sciences annual working capital?
The current annual working capital of AVXL is $120.26 M
What is the all time high annual working capital for Anavex Life Sciences?
Anavex Life Sciences all-time high annual working capital is $150.82 M
What is Anavex Life Sciences annual working capital year-on-year change?
Over the past year, AVXL annual working capital has changed by -$21.59 M (-15.22%)
What is Anavex Life Sciences quarterly working capital?
The current quarterly working capital of AVXL is $120.26 M
What is the all time high quarterly working capital for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly working capital is $157.15 M
What is Anavex Life Sciences quarterly working capital year-on-year change?
Over the past year, AVXL quarterly working capital has changed by -$9.52 M (-7.33%)